{"result": {"id": "chatcmpl-48", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Angiogenesis Research Community\",\n    \"summary\": \"This community focuses on angiogenesis research, exploring its mechanisms and potential applications in various fields like cancer treatment and tissue regeneration. The entities within this community are interconnected through their roles in promoting or inhibiting angiogenesis, with a focus on specific molecules and cell types.  The community's impact is significant due to the potential for developing novel therapies based on these discoveries.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"This community has a high impact severity rating as it focuses on fundamental biological processes that are crucial for various diseases and therapeutic interventions. The research conducted within this community holds the potential to revolutionize healthcare by developing new treatments for cancer, cardiovascular disease, and other conditions.\",\n    \"findings\": [\n        {\n            \"summary\": \"Low-dose PDT reverses ALK1 inhibition effects\",\n            \"explanation\": \"This finding highlights a significant interaction between low-dose PDT and ALK1 inhibition.  The combination of these treatments appears to have an antagonistic effect, potentially reversing the inhibitory effects of ALK1 inhibition. This suggests that low-dose PDT may be a promising therapeutic strategy for cancer treatment by targeting specific pathways involved in angiogenesis. The exact mechanisms behind this interaction require further investigation. [Data: Low-dose PDT (4), ALK1 Inhibition (2)]\"\n        },\n        {\n            \"summary\": \"EFNA3 overexpression inhibits HUVEC migration and angiogenesis\",\n            \"explanation\": \"This finding demonstrates the role of EFNA3 in regulating angiogenesis. Overexpression of EFNA3 significantly reduces HUVEC migration and angiogenesis, suggesting a potential target for therapeutic intervention. This could be achieved through targeting EFNA3 expression or its downstream signaling pathways to inhibit angiogenesis. [Data: EFNA3 overexpression (2163), HUVEC migration (4)]\"\n        },\n        {\n            \"summary\": \"AMG232 inhibits GEC angiogenesis\",\n            \"explanation\": \"This finding reveals the potential of AMG232 as a therapeutic agent for angiogenesis-related diseases.  AMG232 effectively inhibits angiogenesis in GECs, suggesting its potential to be used in developing new treatments for various conditions. [Data: AMG232 (893), GEC angiogenesis (893)]\"\n        },\n        {\n            \"summary\": \"miR-423-5p regulates EFNA3 expression\",\n            \"explanation\": \"This finding highlights the role of miR-423-5p in regulating EFNA3 expression.  The downregulation of miR-423-5p leads to increased EFNA3 expression, suggesting a potential regulatory mechanism for angiogenesis. This could be exploited for developing targeted therapies that modulate EFNA3 levels and subsequently control angiogenesis. [Data: miR-423-5p (2162), EFNA3 expression (2162)]\"\n        },\n        {\n            \"summary\": \"Exosomes promote HUVEC migration and angiogenesis\",\n            \"explanation\": \"This finding demonstrates the role of exosomes in promoting angiogenesis. Exosomes loaded with specific molecules can stimulate HUVEC migration and angiogenesis, highlighting their potential as therapeutic agents for tissue regeneration and wound healing. [Data: Exosomes (397), HUVEC migration (4)]\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743219664, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 711, "prompt_tokens": 2048, "total_tokens": 2759, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n2349,HU-231,Experimental model of tumor angiogenesis,3\n4134,BA,\"The **BA** molecule is known to induce apoptosis (programmed cell death) in human umbilical vein endothelial cells (HUVECs).  It also exhibits the ability to inhibit vascular endothelial growth factor (VEGF) activity. \n\",5\n107,APOPTOSIS,\"The **aptosis** is a programmed form of cell death. It's also known as **programmed cell death**, and it's a process that occurs in a controlled manner within an organism.  This process involves the dismantling of cells in a specific way, ensuring they are removed without causing damage to surrounding tissues. \n\",11\n172,TUMOR ANGIOGENESIS,\"**Tumour angiogenesis** refers to the process of forming new blood vessels within a tumour. This process, essential for tumour growth, allows tumours to receive the necessary nutrients and oxygen from the surrounding environment.  It is also known as **new blood vessel formation in tumors**. \n\",2\n173,CANCER RESEARCH,Research focused on understanding and treating cancer,1\n1205,HUASMC,Human Uterine Arterial Smooth Muscle Cell,1\n2135,VANDETANIB,\"**Vandetanib** is a drug that inhibits the viability of human umbilical vein endothelial cells (HUVECs), meaning it prevents these cells from proliferating and forming new blood vessels. It also acts as an angiogenesis inhibitor, blocking the process of new blood vessel formation.  Vandetanib is primarily used to treat cancer by targeting specific pathways involved in tumor growth and progression. This drug has been shown to inhibit tube formation, a key step in angiogenesis, further supporting its role in cancer treatment. \n\",5\n105,HUVEC,\"The **HUVEC** is a cell type commonly used in angiogenesis assays.  Specifically, it refers to human umbilical vein endothelial cells (HUVECs), which are a type of cell found in the umbilical veins of humans. These cells are widely used in research due to their role in forming blood vessels and their ability to be cultured in laboratories. \n\",6\n1350,CELECOXIB,\"**CELECOXIB** is a drug name. It is also a drug that enhances the effect of vandetanib, and it inhibits HUVEC viability, PTGS2, and tube formation.  It is used to treat pain and axSpA. \n\",5\n3487,ISCHEMIC HEART DISEASE,\"Ischemic heart disease is a common cause of mortality, characterized by a lack of blood flow to the heart. \n\",7\n4277,CARDIAC ANGIOGENESIS,,2\n5521,KOLAVIRON,A bioflavonoid complex found in Garcinia kola seed,8\n5534,BPH,Benign prostatic hyperplasia,1\n5536,TP-TREATED RATS,,1\n5537,CASPASE 3,,1\n5538,ANTI-OXIDATIVE,,1\n5539,ANTI-INFLAMMATORY,,1\n1088,ALVEOLAR BONE DEFECT,Bone defect in the alveolar bone,2\n4274,DEVELOPING COUNTRIES,Countries with less developed healthcare systems,1\n4275,DEVELOPED COUNTRIES,Countries with more developed healthcare systems,1\n4276,RECONSTRUCTION,,1\n1083,HUCMSC-EXOS,\"The **HUCMSC-EXOS** entity refers to a type of cell, specifically **human umbilical cord mesenchymal stem cells (HUCMSCs)**, that stimulates the proliferation, migration, and tube formation of **Human Umbilical Vein Endothelial Cells (HUVECs)**. These exosomes are derived from HUCMSCs and play a role in promoting angiogenesis. \n\",4\n1087,ALVEOLAR BONE DEFECTS,,3\n1773,FUCOXANTHIN,\"**Fucoxanthin** is a marine carotenoid known for its bioactive compounds. It exhibits anti-cancer properties, making it a subject of interest in the field of medicine and research. \n\",6\n1779,CELL CYCLE,\"The **cell cycle** is the series of events that occur within a cell as it grows and divides. This process encompasses the stages of growth, DNA replication, and ultimately cell division.  It's essentially the life cycle of a cell. \n\",1\n1780,AUTOPHAGY,Autophagy is a process where cells break down their own components,1\n1781,PATHWAYS,,1\n111,BCL-2,\"The **BCL-2** protein is a crucial component of the cell cycle, playing a role in regulating its progression. It also functions as an oncogene, meaning it can contribute to the development and growth of tumors by inhibiting apoptosis, or programmed cell death.  This inhibition of apoptosis allows cancer cells to survive and proliferate unchecked.  Furthermore, BCL-2 is known to be involved in tumor growth. \n\",2\n2141,VANDETANIB COMBINATION,,1\n2142,CELECOXIB COMBINATION,,1\n1086,3D-PRINTED SF/COL-I/NHA,,2\n1089,3D-PRINTED SF/COL-I/NHA SCAFFOLDS,,1\n2214,AMG232,\"The entity **AMG232** is a drug that targets cancer cells by blocking the interaction between the MDM2 protein and p53. This action inhibits the growth of cancer cells, as well as angiogenesis (the formation of new blood vessels). \n\",2\n2216,GEC,Cells that make up the blood vessels of the brain,3\n171,P53,\"The **P53** protein is a crucial tumor suppressor protein. It plays a vital role in regulating the cell cycle, ensuring proper cell division and growth.  Additionally, P53 is involved in apoptosis, a process of programmed cell death, which helps eliminate damaged or potentially cancerous cells. This protein's ability to control both cell cycle progression and apoptosis makes it essential for maintaining cellular integrity and preventing tumor development. \n\",2\n2348,MDA-MB-231,Breast cancer cell line,2\n1084,EXOS,\"**EXOS** is a material used for cell attachment and proliferation, and it's also a type of cell used in research.  Specifically, EXOS are small vesicles known as exosomes that can carry molecules and proteins. \n\",2\n1085,SF/COL-I/NHA,\"The **SF/COL-I/NHA** material is used in both 3D printing applications and the creation of bone tissue scaffolds.  It serves as a key component in these processes, enabling the fabrication of intricate structures for various purposes. \n\",1\n2217,RBM4,,1\n2352,LOW-DOSE PDT,,3\n2353,ALK1 INHIBITOR,,1\n2354,ALK1 KNOCKDOWN,,1\n5014,HUCMSC-EVS,Extracellular vesicles derived from human mesenchymal stem cells,2\n5016,EFNA3 OVEREXPRESSION,,2\n5015,MIR-423-5P,,2\n755,GLIO,\"Glio is a type of brain tumor and a form of cancer that affects the brain. \n\",1\n2024,EFNA3,A gene involved in angiogenesis,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n952,HU-231,HUVECS,Human umbilical vein endothelial cells co-cultured with breast cancer MDA-MB-231 cells to create a model of tumor angiogenesis,40\n1698,BA,HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS,\"BA inhibits VEGF-stimulated survival, proliferation, migration, and triggers apoptosis activity in HUVECs\",15\n46,APOPTOSIS,TUMOR ANGIOGENESIS,Apoptosis inhibits tumor angiogenesis,13\n47,APOPTOSIS,CANCER RESEARCH,Cancer research focuses on apoptosis to inhibit tumor growth,12\n456,HUASMC,APOPTOSIS,HUASMC proliferation and apoptosis are regulated by A2M,12\n843,VANDETANIB,HUVEC,Vandetanib inhibited HUVEC viability in a dose-dependent manner,11\n847,CELECOXIB,HUVEC,Celecoxib inhibited HUVEC viability in a dose-dependent manner,11\n1795,ISCHEMIC HEART DISEASE,CARDIAC ANGIOGENESIS,Cardiac angiogenesis is the process of new blood vessel formation in the heart,9\n2361,KOLAVIRON,BPH,Kolaviron prevents BPH by regulating androgen/androgen receptor signaling,9\n2362,KOLAVIRON,TP-TREATED RATS,Treatment with TP and Kolaviron promoted apoptosis in rats,9\n2363,KOLAVIRON,CASPASE 3,Kolaviron upregulates Caspase 3 expression,9\n2367,KOLAVIRON,ANTI-OXIDATIVE,Kolaviron has anti-oxidative effects,9\n2368,KOLAVIRON,ANTI-INFLAMMATORY,Kolaviron has anti-inflammatory effects,9\n404,HUVEC,ALVEOLAR BONE DEFECT,HUVECs are involved in the process of repairing alveolar bone defects,8\n1789,ISCHEMIC HEART DISEASE,DEVELOPING COUNTRIES,IHD is a leading cause of mortality in developing countries,8\n1790,ISCHEMIC HEART DISEASE,DEVELOPED COUNTRIES,IHD is a leading cause of mortality in developed countries,8\n1793,ISCHEMIC HEART DISEASE,RECONSTRUCTION,Reconstruction of the vascular network in the heart after a heart attack is important for recovery,8\n400,HUCMSC-EXOS,ALVEOLAR BONE DEFECTS,\"hUCMSC-Exos were implanted into alveolar bone defects to study bone regeneration and angiogenesis\nhUCMSC-Exos and 3D-printed SF/COL-I/nHA scaffolds were implanted into alveolar bone defects to study bone regeneration and angiogenesis\",7\n679,FUCOXANTHIN,CELL CYCLE,Fucoxanthin inhibits cell cycle progression,7\n681,FUCOXANTHIN,AUTOPHAGY,Fucoxanthin promotes autophagy in cancer cells,7\n683,FUCOXANTHIN,PATHWAYS,\"Fucoxanthin activates pathways like PI3K/Akt, autophagy, and apoptosis in cancer cells\",7\n1700,BA,BCL-2,BA increased the expression of proapoptotic protein Bcl-2,7\n403,HUCMSC-EXOS,ALVEOLAR BONE DEFECT,hUCMSC-Exos promote alveolar bone defect repair,6\n844,VANDETANIB,VANDETANIB COMBINATION,The combination of vandetanib and celecoxib inhibited HUVEC viability more than either drug alone,6\n848,CELECOXIB,CELECOXIB COMBINATION,The combination of celecoxib and vandetanib inhibited HUVEC viability more than either drug alone,6\n399,3D-PRINTED SF/COL-I/NHA,ALVEOLAR BONE DEFECTS,The 3D-printed material was used for research in the alveolar bone defect,5\n402,HUCMSC-EXOS,3D-PRINTED SF/COL-I/NHA SCAFFOLDS,hUCMSC-Exos combined with 3D-printed scaffolds to promote alveolar bone defect repair,5\n892,AMG232,GEC,AMG232 inhibits the proliferation of GECs,5\n894,P53,GEC,p53 reactivates in response to AMG232,5\n950,MDA-MB-231,HU-231,MDA-MB-231 cells were used to construct an experimental model of tumor angiogenesis induced by low-dose PDT,5\n397,EXOS,3D-PRINTED SF/COL-I/NHA,Exos were loaded onto 3D-printed SF/COL-I/nHA scaffolds for research,4\n398,SF/COL-I/NHA,ALVEOLAR BONE DEFECTS,The material used for 3D printing was implanted into alveolar bone defects to study bone regeneration and angiogenesis,4\n895,GEC,RBM4,RBM4 is expressed at low levels in GECs,4\n955,LOW-DOSE PDT,ALK1 INHIBITOR,\"Low-dose PDT reversed the effects of ALK1 inhibition\nAn ALK1 inhibitor reversed the effects of low-dose PDT\",4\n956,LOW-DOSE PDT,ALK1 KNOCKDOWN,\"A knockdown of ALK1 using adenovirus also reversed the effects of low-dose PDT\nLow-dose PDT reversed the effects of ALK1 knockdown\",4\n2162,HUCMSC-EVS,EFNA3 OVEREXPRESSION,Overexpression of EFNA3 reversed the promoting effects of EVs on HUVEC migration and angiogenesis,4\n2164,MIR-423-5P,EFNA3 OVEREXPRESSION,miR-423-5p inhibited EFNA3 expression,4\n893,AMG232,GLIO,AMG232 inhibits the angiogenesis of GECs,3\n2163,EFNA3,MIR-423-5P,miR-423-5p inhibited EFNA3 expression,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_98c22800109d7e9b587034f3d29d3fae8ace382f90bbcf8911f7279a501c9240_v2"}